Joint Panel Composition and Selection Sample Clauses

Joint Panel Composition and Selection a. The Joint Panel shall be made up of four classroom teachers elected by teachers; one from kindergarten, one from grades 1-3, one from grades 4-6, and one from grades 7-8, in secret ballot elections conducted by the Association and three administrators, at least one being a site administrator, appointed by the District.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Joint Panel Composition and Selection. 19.6.1 The PAR program is supervised and evaluated by a Joint Panel composed of a majority of certificated classroom teachers chosen to serve by other certificated classroom teachers and administrators chosen to serve by the district, as follows: two administrators selected by the superintendent and three teachers selected by the Association. The chair will be chosen annually by the Joint Panel. A Panel year is defined as July 1 - June 30. A Panel Member's term shall be no more than three years. For the first year, those selected shall be randomly appointed for two or three year terms.
Sample 1Sample 2
Joint Panel Composition and Selection. The PAR program is supervised and evaluated by a Joint Panel composed of a majority of certificated classroom teachers chosen to serve by other certificated classroom teachers chosen to serve by other certificated classroom teachers and administrators chosen to serve by the District, as follows: three administrators selected by the superintendent and four teachers selected by the association. A panel year is defined as July 1 – June 30. A Panel Member’s term shall be no more than three years. Panel Members must be off the panel for at least one year before being re-selected. For the first year, those selected shall be randomly appointed for two or three year terms. The Panel shall select a chairperson each year. The panel shall invite the District Induction Support Administrator in on discussions regarding all coordination of the PAR Program.
Sample 1
Joint Panel Composition and Selection. The PAR program is supervised and evaluated by a Joint Panel composed of a majority of certificated classroom teachers chosen to serve by other certificated classroom teachers and administrators chosen to serve by the District, as follows: three administrators selected by the superintendent and four teachers selected by the Association, to include a representative from elementary, middle, and high school levels, and the president or designee. The chair alternates annually between a teacher and an administrator. A Panel year is defined as July 1 - June 30. A Panel Member’s term shall be no more than three years. Panel Members must be off the panel for at least one year before being re-selected. For the first year, those selected shall be randomly appointed for two or three year terms.
Sample 1
Joint Panel Composition and Selection. 19.6.1 The PAR program is supervised and evaluated by a Joint Panel composed of a majority of certificated classroom teachers chosen to serve by other certificated classroom teachers and administrators chosen to serve by the district, as follows: two administrators selected by the Superintendent and three teachers selected by the Association. The chair will be chosen annually by the Joint Panel.
Sample 1
Joint Panel Composition and Selection. The PAR program is supervised 16 and evaluated by a Joint Panel. The JP shall consist of five (5) members, 17 the majority of whom shall be permanent certificated classroom teachers 18 chosen by HTA. HTA shall appoint three (3) teachers to the JP. The 19 District shall appoint two (2) administrators to the JP. The District and 20 HTA shall each appoint one (1) alternate to serve in the event of an 21 absence of a regularly appointed member. The Chair alternates annually 22 between a teacher and an administrator. A panel year is defined as July1 23 through June 30. The Panel members’ term shall be no more than three (3) 24 years. Panel members must be off the panel for at least one (1) year before 25 being re-selected. For the first year, one (1) teacher and one administrator 26 shall be appointed for a one (1) year term; one (1) teacher and one (1)
Sample 1

Related to Joint Panel Composition and Selection

  • Committee Composition and Selection 1. The committee shall be comprised of eight members as follows: • five Teachers • three administrators

  • Committee Composition The Redeployment Committee shall be comprised of equal numbers of representatives of the Hospital and of the Union. The number of representatives will be determined locally. Where for the purposes of HTAP (the Ontario Hospital Training and Adjustment Panel) there is another hospital-wide staffing and redeployment committee created or in existence, Union members of the Redeployment Committee shall serve on any such hospital-wide staffing committee established with the same or similar terms of reference, and the number of Union members on such committee will be proportionate to the number of its bargaining unit members at the particular Hospital in relation to other staff groups. Meetings of the Redeployment Committee shall be held during normal working hours. Time spent attending such meetings shall be deemed to be work time for which the representative(s) shall be paid by the Hospital at his or her regular or premium rate as may be applicable. Each party shall appoint a co-chair for the Redeployment Committee. Co-chairs shall chair alternative meetings of the Committee and will be jointly responsible for establishing the agenda of the Committee meetings, preparing minutes and writing such correspondence as the Committee may direct.

  • Selection of Candidates 5.12 The Appointments Committee shall consider all candidates for a Probationary, Tenured, Limited-Term, Externally-Funded or Visiting position and shall interview all short-listed candidates who present themselves for interview.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

Time is Money Join Law Insider Premium to draft better contracts faster.